https://clinicaltrials.gov/ct2/show/NCT03943290?type=Intr&cond=Charcot-Marie-Tooth&lupd_s=04%2F25%2F2019&lupd_d=14
Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)
Conditions : Facioscapulohumeral Muscular Dystrophy; Charcot-Marie-Tooth Disease
Intervention : Drug: ACE-083
Sponsor : Acceleron Pharma, Inc.
Recruiting
NCT03943290
Thu, 09 May 2019 12:00:00 EDT